Literature DB >> 26984593

Transient ischemic attack as an unusual initial manifestation of acute promyelocytic leukemia.

Lifeng Liu1, Xiaoling Yuan2.   

Abstract

Patients with acute promyelocytic leukemia (APL) are prone to both bleeding and thrombosis. Both of these have a significant impact on the morbidity and mortality of patients with this disease. Here we report a case of a 41-year-old male, who presented with transient ischemic attack (TIA) and early neurological deterioration (END) as initial manifestations prior to an ultimate diagnosis of APL. This patient had no cerebrovascular risk factors or familial cerebrovascular disease. The patient experienced an acute ischemic stroke, verified by magnetic resonance imaging (MRI), in less than 24 h after his second hospital admission. Some APL patients suffer from cerebral ischemia as an initial manifestation or during induction therapy, and patients presenting this condition may continue to deteriorate until their death during hospitalization. Thus, APL should be considered as a possible underlying disease in patients with TIA without cerebrovascular risk factors. Delayed diagnosis and treatment of APL can be fatal.

Entities:  

Keywords:  Acute promyelocytic leukemia (APL); All-trans-retinoic acid (ATRA); Coagulopathy; Magnetic resonance imaging (MRI); Transient ischemic attack (TIA)

Mesh:

Year:  2016        PMID: 26984593     DOI: 10.1007/s12185-016-1982-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

Review 1.  Thromboembolic and bleeding complications in acute leukemia.

Authors:  Hau C Kwaan; Timothy Huyck
Journal:  Expert Rev Hematol       Date:  2010-12       Impact factor: 2.929

2.  Transient ischemic attack as initial manifestation of acute promyelocytic leukemia.

Authors:  Laura Cicconi; Graziella Madeo; Safaa M Ramadan; Vittorio Forte; Nicola Mercuri; Francesco Lo-Coco
Journal:  Leuk Res       Date:  2011-04-05       Impact factor: 3.156

3.  Myocardial infarction with intracardiac thrombosis as the presentation of acute promyelocytic leukemia: diagnosis and follow-up by cardiac magnetic resonance imaging.

Authors:  Thomas J Cahill; Oni Chowdhury; Saul G Myerson; Oliver Ormerod; Neil Herring; David Grimwade; Tim Littlewood; Andy Peniket
Journal:  Circulation       Date:  2011-03-15       Impact factor: 29.690

4.  Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features.

Authors:  M Breccia; G Avvisati; R Latagliata; I Carmosino; A Guarini; M S De Propris; F Gentilini; M C Petti; G Cimino; F Mandelli; F Lo-Coco
Journal:  Leukemia       Date:  2006-08-24       Impact factor: 11.528

5.  Cerebellar infarction with hypertriglyceridemia during all-trans retinoic acid therapy for acute promyelocytic leukemia.

Authors:  H Fujiwara; Y Umeda; S Yonekura
Journal:  Leukemia       Date:  1995-09       Impact factor: 11.528

Review 6.  [Cerebrovascular complications of cancers].

Authors:  F Dubas; I Serre
Journal:  Rev Neurol (Paris)       Date:  1992       Impact factor: 2.607

Review 7.  Thrombosis in acute promyelocytic leukemia.

Authors:  Armin Rashidi; Marc L Silverberg; Paul R Conkling; Stephen I Fisher
Journal:  Thromb Res       Date:  2012-12-23       Impact factor: 3.944

Review 8.  The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.

Authors:  Martin S Tallman; Syed A Abutalib; Jessica K Altman
Journal:  Semin Thromb Hemost       Date:  2007-06       Impact factor: 4.180

Review 9.  Acute promyelocytic leukemia.

Authors:  R P Warrell; H de Thé; Z Y Wang; L Degos
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

10.  The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature.

Authors:  Pau Montesinos; Miguel A Sanz
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-04       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.